• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail
-

GRN No. 41

Substance: DHASCO (docosahexaenoic acid-rich single-cell oil) and ARASCO (arachidonic acid-rich single-cell oil)
Intended Use: Provide DHASCO (as a source of docosahexaenoic acid) and ARASCO (as a source of arachidonic acid) in term infant formula, at a maximum level of 1.25 percent each of the total dietary fat and at a ratio ranging from 1:1 to 1:2 (DHASCO:ARASCO)
Basis: Scientific procedures
Notifier: Martek Biosciences Corporation
6480 Dobbin Road; Columbia, MD 21045
Date of filing: Mar 1, 2000
GRAS Notice (releasable information): 41
Date of closure / FDA's Letter: May 17, 2001
FDA has no questions
-
-